Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 1 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 3Thoracic 1Head & Neck 1CNS 1

Conditions

Prostatic Neoplasms 147Breast Neoplasms 108Lung Neoplasms 92Carcinoma, Non-Small-Cell Lung 77Neoplasm Metastasis 68Glioblastoma 68Brain Neoplasms 64Glioma 59Pancreatic Neoplasms 45Carcinoma, Renal Cell 43Multiple Myeloma 41Squamous Cell Carcinoma of Head and Neck 39Colorectal Neoplasms 38Lymphoma, Large B-Cell, Diffuse 37Neoplasms 34Melanoma 32Lymphoma 32Carcinoma, Hepatocellular 32Urinary Bladder Neoplasms 31Ovarian Neoplasms 29Astrocytoma 28Sarcoma 25Oropharyngeal Neoplasms 24Lymphoma, Follicular 23Central Nervous System Neoplasms 23Rectal Neoplasms 22Uterine Cervical Neoplasms 21Triple Negative Breast Neoplasms 21Mouth Neoplasms 21Lymphoma, Non-Hodgkin 21

Interventions

Magnetic Resonance Spectroscopy 6Dexamethasone 6Cyclophosphamide 6Blood Specimen Collection 6Prednisone 5Positron Emission Tomography Computed Tomography 4Mammography 4Lenalidomide 4Colonoscopy 4pembrolizumab 3Tomography, X-Ray Computed 3Surveys and Questionnaires 3Melphalan 3Exercise 3Biopsy 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3weifuchun 2obinutuzumab 2fluciclovine F-18 2daratumumab 2carfilzomib 2Preoperative Exercise 2Positron-Emission Tomography 2Methods 2Magnetic Resonance Imaging 2Injections 2Gemcitabine 2Educational Status 2Doxorubicin 2Cytarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Disease × Magnetic Resonance Spectroscopy × Clear all
NCT00633958 2021-10-20

FLT

Dana-Farber Cancer Institute

Phase 1 Terminated
2 enrolled
CNS

Disease, Central Nervous System Neoplasms

NCT02022579 2018-10-11

ACRIN6702

American College of Radiology Imaging Network

Phase NA Unknown
100 enrolled
Breast

Breast Neoplasms, Disease

NCT02865239 2018-08-08

EFIMED

Institut de Cancérologie de Lorraine

Phase NA Completed
15 enrolled
Breast

Breast Neoplasms, Disease

NCT00136890 2013-01-15

ELPET

Ontario Clinical Oncology Group (OCOG)

Phase 3 Completed
337 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Neoplasms

NCT00147472 2012-06-22

Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)

Ontario Clinical Oncology Group (OCOG)

Phase 3 Completed
400 enrolled
Head & Neck

Disease, Head and Neck Neoplasms, Neoplasms

NCT00201942 2007-10-18

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

Ontario Clinical Oncology Group (OCOG)

Phase 3 Completed
336 enrolled
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡